Actinium Pharmaceuticals (ATNM) Debt Ratio (2010 - 2014)

Actinium Pharmaceuticals (ATNM) posted quarterly Debt Ratio of 0.0 for Q2 2014, down 75.29% quarter-over-quarter from 0.01 in Q1 2014.

Actinium Pharmaceuticals (ATNM) Debt Ratio (2010 - 2014) Analysis & Trends

Actinium Pharmaceuticals (ATNM) has reported Debt Ratio for 5 consecutive years, with 0.0 the latest figure, recorded in Q2 2014.

In Q2 2014, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2014 stood at 0.0 (changed N/A YoY), while the FY2013 annual figure was 0.03, changed N/A from the prior year.
Debt Ratio slipped to 0.0 in Q2 2014 per ATNM's latest filing, from 0.01 in the prior quarter.
Across five years, Debt Ratio topped out at 501.83 in Q2 2012 and bottomed at 0.0 in Q2 2014.
Historically, Debt Ratio has averaged 188.73 across 5 years, with a median of 0.03 in 2013.
On a YoY basis, Debt Ratio climbed as much as 100.0% in 2011 and fell as far as 100.0% in 2011.
Actinium Pharmaceuticals' Debt Ratio stood at 391.38 in 2010, then sank by 100.0% to 0.01 in 2011, then soared by 5349235.58% to 501.83 in 2012, then slumped by 99.99% to 0.03 in 2013, then plunged by 87.0% to 0.0 in 2014.
Business Quant data shows ATNM's Debt Ratio at 0.0 in Q2 2014, 0.01 in Q1 2014, and 0.03 in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	Actinium Pharmaceuticals	35.01 Mn	35.01 Mn	-	-

Download Data